#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Amyotrophic lateral sclerosis gene carrier Cerebellar ataxia Dementia Alzheimer's type Proteus syndrome Soft tissue sarcoma Vulval cancer recurrent Glioblastoma Deafness bilateral Erythema Acute promyelocytic leukaemia Retinopathy proliferative Acute hepatic failure Congenital growth hormone deficiency Peritoneal mesothelioma malignant Prophylaxis against transplant rejection More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma – Diagnostics Encephalitis autoimmune – Trials in Disease Cystic fibrosis – Basic Information Breast angiosarcoma – Treatment Langerhans’ cell histiocytosis – Treatment Waldenstrom’s macroglobulinaemia – Diagnostics Uterine leiomyosarcoma – Life with Disease Lymphangioma – Trials in Disease Antithrombin III deficiency Haemophilia A with anti factor VIII – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Pal1-15 Acetate Diacerein Opelconazole Dmd06-Mab 6QC-ICG Peboctocogene Camaparvovec LY3537021 Netupitant Montelukast Verapamil Psilocybine Amikacin RIVASTIGMINE Isis 696844 Arginine Hydrochloride Efruxifermin [18F]Alf-Nota-Octreotide Viltolarsen Xylitol Elotuzumab More therapies…

    Learn about Your Condition

    Dementia Alzheimer's type Asplenia Facial paresis Fatty acid oxidation disorder Herpes simplex reactivation Red blood cell abnormality Testicular germ cell tumour Androgenetic alopecia Procedural haemorrhage Actinic keratosis Lung disorder Testicular germ cell cancer Lichen planopilaris Anxiety disorder Chronic granulomatous disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Alzheimer’s Disease Using Flortaucipir (18F) for Early Diagnosis in At-Risk Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Flortaucipir (18F)
    France

  • Study on Midostaurin and Gemtuzumab Ozogamicin for Adults with Acute Myeloid Leukemia

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Gemtuzumab Ozogamicin
    • Midostaurin
    • Daunorubicin Hydrochloride
    Germany

  • Study on Reducing Treatment for Stage IIa/IIb Seminoma Using Etoposide, Cisplatin, and Carboplatin in Patients with Tumors Smaller than 3 cm

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Etoposide
    France

  • Study on Personalized Dosing of Sertraline, Aripiprazole, and Risperidone for Patients with Mood, Anxiety, or Psychotic Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Affective disorder
    • Psychotic disorder
    • Anxiety disorder
    Investigated Drugs:
    • Aripiprazole
    • Risperidone
    • Escitalopram
    Germany The Netherlands Spain

  • Study on Ponatinib and Imatinib for Adults with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Imatinib
    • Ponatinib
    • Blinatumomab
    Germany

  • Study of ART27.13 for Patients with Cancer-Related Anorexia and Weight Loss

    Recruiting

    2 1
    Investigated Diseases:
    • Decreased appetite
    Investigated Drugs:
    • N-{2-Tert-Butyl-1-[(4,4-Difluorocyclohexyl)Methyl]-1H-1,3-Benzodiazol-5-Yl}Ethane-1-Sulfonamide
    • Placebo
    Ireland Norway
Previous Page
1 … 410 411 412 413 414 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!